BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19642906)

  • 1. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.
    Zhou Y; Li M; Wei Y; Feng D; Peng C; Weng H; Ma Y; Bao L; Nallar S; Kalakonda S; Xiao W; Kalvakolanu DV; Ling B
    J Interferon Cytokine Res; 2009 Oct; 29(10):695-703. PubMed ID: 19642906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo.
    Wang T; Yan XB; Zhao JJ; Ye J; Jiang ZF; Wu DR; Xiao WH; Liu RY
    Lung Cancer; 2011 Jun; 72(3):287-93. PubMed ID: 21040996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of a gene associated with retinoid-interferon-induced mortality 19 (GRIM-19) on STAT3-induced gene expression in renal carcinoma.
    Cui L; Meng Q; Wen J; Yan Z; Gao Z; Tian Y; Xu P; Lian P; Yu H
    J Biochem; 2018 Oct; 164(4):285-294. PubMed ID: 29961871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma.
    Li F; Ren W; Zhao Y; Fu Z; Ji Y; Zhu Y; Qin C
    Med Oncol; 2012 Dec; 29(5):3046-54. PubMed ID: 22492280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRIM-19 inhibition induced autophagy through activation of ERK and HIF-1α not STAT3 in Hela cells.
    Yue X; Zhao P; Wu K; Huang J; Zhang W; Wu Y; Liang X; He X
    Tumour Biol; 2016 Jul; 37(7):9789-96. PubMed ID: 26810068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
    Kalakonda S; Nallar SC; Gong P; Lindner DJ; Goldblum SE; Reddy SP; Kalvakolanu DV
    Am J Pathol; 2007 Oct; 171(4):1352-68. PubMed ID: 17823279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
    Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
    Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
    Wu N; Hui H; Cui L; Yang F
    Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a structural motif in the tumor-suppressive protein GRIM-19 required for its antitumor activity.
    Nallar SC; Kalakonda S; Sun P; Ohmori Y; Hiroi M; Mori K; Lindner DJ; Kalvakolanu DV
    Am J Pathol; 2010 Aug; 177(2):896-907. PubMed ID: 20595633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis.
    Kalakonda S; Nallar SC; Lindner DJ; Sun P; Lorenz RR; Lamarre E; Reddy SP; Kalvakolanu DV
    Oncogene; 2014 Jun; 33(24):3195-204. PubMed ID: 23851499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
    Nallar SC; Kalakonda S; Lindner DJ; Lorenz RR; Lamarre E; Weihua X; Kalvakolanu DV
    J Biol Chem; 2013 Mar; 288(11):7930-7941. PubMed ID: 23386605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlations of GRIM-19 and its target gene product STAT3 to malignancy of human colorectal carcinoma].
    Gong LB; Luo XL; Liu SY; Tao DD; Gong JP; Hu JB
    Ai Zheng; 2007 Jul; 26(7):683-7. PubMed ID: 17626740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
    Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
    Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
    Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
    Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling.
    Kong D; Chen J; Sun X; Lin Y; Du Y; Huang D; Cheng H; He P; Yang L; Wu S; Zhao L; Meng X
    Biosci Trends; 2019; 13(4):342-350. PubMed ID: 31527330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRIM-19 in Health and Disease.
    Máximo V; Lima J; Soares P; Silva A; Bento I; Sobrinho-Simões M
    Adv Anat Pathol; 2008 Jan; 15(1):46-53. PubMed ID: 18156812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GRIM-19 disrupts E6/E6AP complex to rescue p53 and induce apoptosis in cervical cancers.
    Zhou Y; Wei Y; Zhu J; Wang Q; Bao L; Ma Y; Chen Y; Feng D; Zhang A; Sun J; Nallar SC; Shen K; Kalvakolanu DV; Xiao W; Ling B
    PLoS One; 2011; 6(7):e22065. PubMed ID: 21765936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Glucose Induces Down-Regulated GRIM-19 Expression to Activate STAT3 Signaling and Promote Cell Proliferation in Cell Culture.
    Li YG; Han BB; Li F; Yu JW; Dong ZF; Niu GM; Qing YW; Li JB; Wei M; Zhu W
    PLoS One; 2016; 11(4):e0153659. PubMed ID: 27101310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.
    Kalakonda S; Nallar SC; Lindner DJ; Hu J; Reddy SP; Kalvakolanu DV
    Cancer Res; 2007 Jul; 67(13):6212-20. PubMed ID: 17616678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-mediated miR-29b expression inhibits the invasion and angiogenesis of cervical cancer.
    Li Y; Zhang Z; Xiao Z; Lin Y; Luo T; Zhou Q; Zhang X
    Oncotarget; 2017 Feb; 8(9):14655-14665. PubMed ID: 28122338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.